Sort
85,873 grants matching “alzheimers”
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,339,366Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2024 · NS
Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease
$2,338,814William C Raschke · Virogenics, Inc. · R01 · FY2022 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,338,571Mount Sinai School Of Medicine Of Nyu · P50 · FY2001 · AG
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
$2,338,540Christopher Mark Norris · University Of Kentucky · RF1 · FY2018 · AG
Frontotemporal Dementias: Genotypes and Phenotypes
$2,337,667Virginia M Lee · University Of Pennsylvania · P01 · FY2017 · AG
Protective roles of taurine in Alzheimer's disease brain
$2,337,294Bruce Jenkins · Massachusetts General Hospital · RF1 · FY2020 · AG
Understanding CSF Clearance in Aging and AlzheimerâÂÂs Brain Through Dynamic Sodium MRI - Resubmission - 1
$2,336,665Yongxian Qian · New York University School Of Medicine · RF1 · FY2021 · AG
Anti-Viral therapy in Alzheimer's disease
$2,335,690Davangere P Devanand · Columbia University Health Sciences · R01 · FY2021 · AG
Brooklyn Women's Interagency HIV Study (WIHS) V
$2,334,866Howard Minkoff · Suny Downstate Medical Center · U01 · FY2018 · AI
Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry
$2,334,254Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2024 · AG
Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics
$2,333,875Ornit Chiba-Falek · Duke University · RF1 · FY2022 · AG
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids
$2,333,853Zhexing Wen · Emory University · RF1 · FY2022 · AG
The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level
$2,333,781Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U24 · FY2024 · AG
Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis
$2,333,674Bruce T Lamb · Indiana University Indianapolis · RF1 · FY2021 · AG
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy
$2,333,228Ethan Lippmann · Vanderbilt University · RF1 · FY2022 · NS
Veterinary and Colony Management Core
$2,332,586Peter L Strick · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG
Investigations of Dementia in Parkinson Disease
$2,332,494Joel Synes Perlmutter · Washington University · RF1 · FY2023 · NS
Long Life Family Study: Data Management and Coordinating Center
$2,332,287Michael A Province · Washington University · U01 · FY2017 · AG
Machine and deep learning for finding multimodal imaging biomarkers in prodromal AD
$2,331,558Dietmar Cordes · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2021 · AG
Alzheimer's Disease Research Center
$2,331,138Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · AG
Prefrontal-cingulate functional networks in aging monkeys: neural circuit substrates of cognitive aging
$2,330,859Maria Medalla · Boston University Medical Campus · RF1 · FY2023 · AG
Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry
$2,330,825Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2021 · AG
Integrative analysis for patient-centered outcomes and time-to-event data in Alzheimer's disease
$2,330,283Yize Zhao · Yale University · RF1 · FY2023 · AG
Evaluation of the neuroimmune mechanisms influencing therapeutic targetingpotential of the LH/CG receptor in the menopausal and AD brain
$2,329,970Gemma Casadesus · University Of Florida · RF1 · FY2025 · AG
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome
$2,328,791Robert A Rissman · University Of California, San Diego · RF1 · FY2021 · AG